Ischemic Preconditioning Clinical Trial
Official title:
Study on the Cardioprotection and Humoral Mechanism of Limb Ischemia Preconditioning
Numerous studies Have shown that limb ischemic preconditioning can protect vital organs (including the heart) from ischemia-reperfusion injury,which has a broad application prospect.But its mechanism is still unclear. Evidence showed that humoral mechanisms may play an important role. This study was carried out on the limb ischemic preconditioning in healthy volunteers, collected their serum at different time points before and after treatment,classified and identified the serum proteins during different periods of limb ischemic preconditioning,by using methods including high abundant protein removal,Two-dimensional electrophoresis chromatography and mass spectrometry,then analysed activation and synthesis of the proteins in order to search for the proteins or peptides whose synthesis was activated by ischemic preconditioning. This study will be the first systemic explore of the changes in serum proteins of limb ischemic preconditioning in human body,and lay theoretical basis for the clinical application of limb ischemic preconditioning and for further explore of its humoral mechanism,thus provide clues for searching for protein or peptide having protective effects for organs.
We aim to assess whether limb ischemic preconditioning protects remote tissue or organs through a humoral mechanism. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01235286 -
Cutaneous Remote Ischemic Preconditioning in Plastic Surgery
|
N/A | |
Completed |
NCT00184912 -
The Effect of Caffeine on Ischemic Preconditioning
|
N/A | |
Recruiting |
NCT03380663 -
Conditioning Based Intervention Strategies
|
N/A | |
Completed |
NCT03023150 -
Ischemic Preconditioning as an Intervention to Improve Stroke Rehabilitation - Froedtert
|
N/A | |
Completed |
NCT02981680 -
Effect of Remote Ischemic Preconditioning on the Incidence of Acute Kidney Injury in Patients Undergoing Coronary Artery Bypass Graft Surgery
|
N/A | |
Completed |
NCT00821522 -
The Influence of Remote Ischemic Preconditioning on Acute Kidney Injury After Cardiac Surgery
|
Phase 1 | |
Active, not recruiting |
NCT01164618 -
The Biology of Chronic Preconditioning: Genomic and Physiologic Mechanisms of Response
|
Phase 2 | |
Not yet recruiting |
NCT05957523 -
Effects of Remote Ischemic Preconditioning on Components of Peripheral Blood and Gut Microbiome (EMINENT)
|
N/A | |
Completed |
NCT04887610 -
Factors That Influence Blood Vessel Regulation During Exercise in Humans
|
N/A | |
Completed |
NCT05219344 -
Tissue Flossing and Lower Limb Neuromuscular Function
|
N/A | |
Completed |
NCT00453531 -
Model System for Transient Forearm Blood Vessel Dysfunction
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05412888 -
Effect of CoQ10 on the Endocrine Function of Skeletal Muscle
|
N/A | |
Recruiting |
NCT03900390 -
The Study of Potency of Cross-preconditioning to Prevent Ischemic-reperfusion Injury for Heart Transplantation Recipient
|
N/A | |
Completed |
NCT02411266 -
Preconditioning With Limb Ischemia for Subarachnoid Hemorrhage
|
N/A | |
Completed |
NCT02666235 -
Remote Ischaemic Conditioning and Coronary Endothelial Function (RIC-COR)
|
Phase 2 | |
Terminated |
NCT01743937 -
A Trial Comparing the Ischemic Preconditioning Effects of Ticagrelor and Clopidogrel in Humans
|
Phase 4 | |
Completed |
NCT04016857 -
Remote Ischemic Preconditioning During Lower Limb Revascularization
|
N/A | |
Not yet recruiting |
NCT05653505 -
Remote Ischemic Conditioning Combined With Endovascular Stenting for Symptomatic Intracranial Atherosclerotic Stenosis
|
||
Completed |
NCT02965547 -
Remote Ischemic Preconditioning of Dynamic Cerebral Autoregulation in Healthy Adults
|
N/A | |
Completed |
NCT05350683 -
Effect of Remote Ischemic Preconditioning on the Incidence of Contrast Induced Nephropathy in Patients Undergoing EVAR
|
Phase 2 |